tiprankstipranks
Trending News
More News >
Silence Therapeutics (SLN)
NASDAQ:SLN

Silence Therapeutics (SLN) Revenue

Compare
158 Followers

Silence Therapeutics Revenue

Silence Therapeutics had a revenue of 24.33M in the quarter ending Dec 31, 2024, with 2030.28%. This bring the company's revenue in the last twelve months to 38.47M, Decreased 136.83%. In the fiscal year ending Dec 31, 2024, Silence Therapeutics had annual revenue of 43.26M with 70.47% growth.
Revenue (ttm)
38.47M
Revenue Growth
-40.10%
P/S Ratio
5.42
Revenue/Employee
$372,914
Employees
116
Market Cap
$234.26M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
43.26M17.88M+70.47%
Dec 31, 2023
25.38M7.87M+44.99%
Dec 31, 2022
17.50M5.09M+40.97%
Dec 31, 2021
12.41M6.94M+126.59%
Dec 31, 2020
5.48M5.24M+2,145.49%
Dec 31, 2019
244.00K+∞%
Dec 31, 2018
0.00-16.00K-100.00%
Dec 31, 2017
16.00K-754.00K-97.92%
Dec 31, 2016
770.00K+∞%
Dec 31, 2015
0.00-15.00K-100.00%
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis